Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1615
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18642098 | STABLE BIOACTIVE GLASS FORMULATIONS | Non-Final OA | CORNING INCORPORATED |
| 18190517 | DENDRON-POLYMER HYBRIDS AS TAILORABLE CORONAE OF SINGLE-WALLED CARBON NANOTUBES AND USES THEREOF | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 18663231 | BONE-REGENERATION-PROMOTING MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL | Non-Final OA | TOHOKU UNIVERSITY |
| 18469762 | CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17757090 | COMPOSITIONS FOR USE IN THE REDUCTION OF NOCICEPTION AND OTHER HEALTH BENEFITS IN INFANTS AND YOUNG CHILDREN | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18699799 | REFILLABLE TISSUE ENGINEERED SCAFFOLDS | Non-Final OA | Board of Regents of the University of Nebraska |
| 18332553 | MATERIALS AND TREATMENTS USING PIEZOELECTRIC EMBOLIC MATERIALS | Non-Final OA | MicroVention, Inc. |
| 18006072 | SILICON-CONTAINING LIGAND COMPOUNDS | Non-Final OA | Technische Universität München |
| 18672288 | ANTICOAGULANT COMPOUNDS COMPRISING CHELATING AGENTS AND CATIONIC ANTI-COAGULATION ENHANCERS AND METHODS AND DEVICES FOR THEIR USE | Non-Final OA | Elixir Medical Corporation |
| 17925582 | TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS | Non-Final OA | The USA as represented by the Secretary, Department of Health and Human Services |
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | Non-Final OA | L.E.A.F. HOLDINGS GROUP LLC |
| 17919952 | LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF | Non-Final OA | Millennium Pharmaceuticals, Inc. |
| 18731515 | INDIGENOUS AND IMPROVED BACTERIALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS | Non-Final OA | Fermented Farmer, LLC |
| 18710132 | OSMOTIC AGENT COMPOSITION COMPRISING ACIDSENSITIVE INGREDIENT | Non-Final OA | ODDSON BIO CO., LTD. |
| 18701320 | METHODS AND SYSTEMS FOR PROCESSING AND FORMULATING PLANT MATERIAL | Non-Final OA | FLOWERPOD, LLC |
| 18629882 | TOPICAL OCULAR THERAPY | Non-Final OA | Moxicaine, LLC |
| 18698144 | AQUEOUS SUSPENSION AGROCHEMICAL COMPOSITION, DISEASE CONTROL METHOD, AND USEFUL PLANT SEEDS | Non-Final OA | KUMIAI CHEMICAL INDUSTRY CO., LTD. |
| 18697608 | AQUEOUS SUSPENSION AGROCHEMICAL COMPOSITION, METHOD FOR PREVENTING CROP DAMAGE, AND USEFUL PLANT SEEDS | Non-Final OA | KUMIAI CHEMICAL INDUSTRY CO., LTD. |
| 18697611 | SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF | Non-Final OA | SZEGEDI TUDOMÁNYEGYETEM |
| 18686004 | LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES | Non-Final OA | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. |
| 18531322 | Method For Cleaning Surfaces And Treatment Solution For Same | Non-Final OA | epitome GmbH |
| 18560451 | A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE | Non-Final OA | BIMEDA ANIMAL HEALTH LIMITED |
| 18254366 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | Final Rejection | Capsugel Belgium NV |
| 18232351 | METHOD OF DELIVERING NUCLEIC ACIDS INTO CELLS | Non-Final OA | GUANGZHOU LIDE BIOMEDICINE TECHNOLOGY CO., LTD. |
| 18038338 | Bioactive complexes | Non-Final OA | Ceradis Patent B.V. |
| 18210977 | FLAVOR BANDING OF CAPSULES | Non-Final OA | L. PERRIGO COMPANY |
| 17925929 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | Final Rejection | LANXESS Organometallics GmbH |
| 17781433 | A COLLAGEN-HYDROXYAPATITE DEVICE FOR NON-SURGICAL PERIODONTAL TREATMENT | Non-Final OA | DATUM DENTAL LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy